BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673 [PMID: 26819531 DOI: 10.3748/wjg.v22.i4.1664] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 49] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 [DOI: 10.1101/510222] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
2 Lim DW, Kim H, Lee SJ, Yu GR, Kim JE, Park WH. Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway. Evid Based Complement Alternat Med 2019;2019:4589810. [PMID: 30881473 DOI: 10.1155/2019/4589810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 van den Brink W, Bloem R, Ananth A, Kanagasabapathi T, Amelink A, Bouwman J, Gelinck G, van Veen S, Boorsma A, Wopereis S. Digital Resilience Biomarkers for Personalized Health Maintenance and Disease Prevention. Front Digit Health 2020;2:614670. [PMID: 34713076 DOI: 10.3389/fdgth.2020.614670] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yoo J, Lee JM, Joo I, Lee DH, Yoon JH, Kang HJ, Ahn SJ. Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. Ultrasonography 2020;39:121-9. [PMID: 31693842 DOI: 10.14366/usg.19034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhao N, Yang S, Jia Y, Sun B, He B, Zhao R. Maternal betaine supplementation attenuates glucocorticoid-induced hepatic lipid accumulation through epigenetic modification in adult offspring rats. The Journal of Nutritional Biochemistry 2018;54:105-12. [DOI: 10.1016/j.jnutbio.2017.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
6 Mohammad S, Al Zoubi S, Collotta D, Krieg N, Wissuwa B, Ferreira Alves G, Purvis GSD, Norata GD, Baragetti A, Catapano AL, Solito E, Zechendorf E, Schürholz T, Correa-Vargas W, Brandenburg K, Coldewey SM, Collino M, Yaqoob MM, Martin L, Thiemermann C. A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice. Front Immunol 2021;12:701275. [PMID: 34349763 DOI: 10.3389/fimmu.2021.701275] [Reference Citation Analysis]
7 Berger E, Géloën A. Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier. Adipocyte 2019;8:83-97. [PMID: 30905315 DOI: 10.1080/21623945.2019.1580842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Han X, Xu S, Lin J. Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In Vitro. CURR MED SCI 2019;39:766-77. [DOI: 10.1007/s11596-019-2104-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Jestin M, Kapnick SM, Tarasenko TN, Burke CT, Zerfas PM, Diaz F, Vernon H, Singh LN, Sokol RJ, McGuire PJ. Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. Mol Metab 2020;37:100981. [PMID: 32283081 DOI: 10.1016/j.molmet.2020.100981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Matilainen J, Mustonen AM, Rilla K, Käkelä R, Sihvo SP, Nieminen P. Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism. Lipids Health Dis 2020;19:70. [PMID: 32284043 DOI: 10.1186/s12944-020-01243-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Cho MK, Seo MJ, Juvekar V, Jo JH, Kim W, Choi KS, Kim HM. Screening of Drug-Induced Steatosis and Phospholipidosis Using Lipid Droplet-Selective Two-Photon Probes. Anal Chem 2020;92:11223-31. [DOI: 10.1021/acs.analchem.0c01728] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
12 Wiśniewska A, Stachowicz A, Kuś K, Ulatowska-Białas M, Totoń-Żurańska J, Kiepura A, Stachyra K, Suski M, Gajda M, Jawień J, Olszanecki R. Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio. Int J Mol Sci 2021;22:10688. [PMID: 34639029 DOI: 10.3390/ijms221910688] [Reference Citation Analysis]
13 Zhang R, Kan JB, Lu S, Tong P, Yang J, Xi L, Liang X, Su D, Li D, Liu Y. S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Biosci Rep 2019;39:BSR20182042. [PMID: 31399502 DOI: 10.1042/BSR20182042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang Y, Zhao H, Yang L, Zhang H, Yu X, Fei W, Zhen Y, Gao Z, Chen S, Ren L. Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice. Bioengineered 2022;13:6750-66. [PMID: 35246007 DOI: 10.1080/21655979.2022.2045837] [Reference Citation Analysis]
15 Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. Journal of Ethnopharmacology 2018;212:208-15. [DOI: 10.1016/j.jep.2017.09.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
16 Li Y, Cao C, Zhou Y, Nie Y, Cao J, Zhou Y. The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver disease. Arab Journal of Gastroenterology 2020;21:162-8. [DOI: 10.1016/j.ajg.2020.04.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ma J, Wei Z, Wang Q, Lu X, Zhou Z, Li R, Shu Q, Liu Y, Wang J, Liu N, Shi H. Association of serum creatinine with hepatic steatosis and fibrosis: a cross-sectional study. BMC Gastroenterol 2022;22:358. [PMID: 35896972 DOI: 10.1186/s12876-022-02437-0] [Reference Citation Analysis]
18 Matsumoto Y, Fujita S, Yamagishi A, Shirai T, Maeda Y, Suzuki T, Kobayashi KI, Inoue J, Yamamoto Y. Brown Rice Inhibits Development of Nonalcoholic Fatty Liver Disease in Obese Zucker (fa/fa) Rats by Increasing Lipid Oxidation Via Activation of Retinoic Acid Synthesis. J Nutr 2021:nxab188. [PMID: 34224565 DOI: 10.1093/jn/nxab188] [Reference Citation Analysis]
19 Arain SQ, Talpur FN, Channa NA, Ali MS, Afridi HI. Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B. Lipids Health Dis 2018;17:36. [PMID: 29506525 DOI: 10.1186/s12944-018-0683-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Jorgačević B, Vučević D, Đuričić I, Šobajić S, Mladenović D, Vesković M, Vukićević RJ, Radosavljević T. The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease. Chem Phys Lipids 2017;204:85-93. [PMID: 28363784 DOI: 10.1016/j.chemphyslip.2017.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
21 Wang Y, Zhu Y, Niu J, Deng Q, Guo S, Jiang H, Peng Z, Xue Y, Peng H, Xuan L, Pan G. A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters. Toxicol Appl Pharmacol 2020;404:115169. [PMID: 32738331 DOI: 10.1016/j.taap.2020.115169] [Reference Citation Analysis]
22 Grünig D, Duthaler U, Krähenbühl S. Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells. Front Pharmacol 2018;9:257. [PMID: 29740314 DOI: 10.3389/fphar.2018.00257] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Sangouni AA, Ghavamzadeh S, Jamalzehi A. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:2260-5. [DOI: 10.1016/j.dsx.2019.05.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
24 Jiang S, Fang DA, Xu D. Transcriptome analysis of Takifugu obscurus liver in response to acute retene exposure. J Environ Sci Health A Tox Hazard Subst Environ Eng 2020;55:1188-200. [PMID: 32558618 DOI: 10.1080/10934529.2020.1780852] [Reference Citation Analysis]
25 Guerra JVS, Dias MMG, Brilhante AJVC, Terra MF, García-Arévalo M, Figueira ACM. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients 2021;13:2830. [PMID: 34444990 DOI: 10.3390/nu13082830] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Leung K, Quezada M, Chen Z, Kanel G, Kaplowitz N. Niacin-Induced Anicteric Microvesicular Steatotic Acute Liver Failure. Hepatol Commun 2018;2:1293-8. [PMID: 30411075 DOI: 10.1002/hep4.1253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
27 Li F, Yang Y, Yang L, Wang K, Zhang X, Zong Y, Ding Y, Wang C, Zhang L, Ji G. Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stress. Oncotarget 2017;8:43799-809. [PMID: 28415630 DOI: 10.18632/oncotarget.16460] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
28 Yao W, Wang T, Xia J, Li J, Yu X, Huang F. Dietary Garcinol Attenuates Hepatic Pyruvate and Triglyceride Accumulation by Inhibiting P300/CBP-Associated Factor in Mid-to-Late Pregnant Rats. J Nutr 2020;150:231-9. [PMID: 31579921 DOI: 10.1093/jn/nxz238] [Reference Citation Analysis]
29 Xie W, Chen S. A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population: A retrospective cohort study. Medicine (Baltimore) 2020;99:e23049. [PMID: 33235066 DOI: 10.1097/MD.0000000000023049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Lukenda Zanko V, Domislovic V, Trkulja V, Krznaric-Zrnic I, Turk-Wensveen T, Krznaric Z, Filipec Kanizaj T, Radic-Kristo D, Bilic-Zulle L, Orlic L, Dinjar-Kujundzic P, Poropat G, Stimac D, Hauser G, Mikolasevic I. Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2020;22:2097-106. [PMID: 32613718 DOI: 10.1111/dom.14129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016;65:1109-23. [DOI: 10.1016/j.metabol.2016.05.003] [Cited by in Crossref: 226] [Cited by in F6Publishing: 195] [Article Influence: 37.7] [Reference Citation Analysis]
32 Shimpi PC, More VR, Paranjpe M, Donepudi AC, Goodrich JM, Dolinoy DC, Rubin B, Slitt AL. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. Environ Health Perspect 2017;125:087005. [PMID: 28796629 DOI: 10.1289/EHP664] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 7.6] [Reference Citation Analysis]
33 Rappez L, Stadler M, Triana S, Gathungu RM, Ovchinnikova K, Phapale P, Heikenwalder M, Alexandrov T. SpaceM reveals metabolic states of single cells. Nat Methods 2021;18:799-805. [PMID: 34226721 DOI: 10.1038/s41592-021-01198-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
34 Farooque U, Lohano AK, Dahri Q, Arain N, Farukhuddin F, Khadke C, Prince F, Farooque R, Shehata MA, Bin Zafar MD. The Pattern of Dyslipidemia in Chronic Liver Disease Patients. Cureus 2021;13:e13259. [PMID: 33728198 DOI: 10.7759/cureus.13259] [Reference Citation Analysis]
35 Ahn SH, Lee KP, Kim K, Choi JY, Park SY, Cheon JH. Dansameum regulates hepatic lipogenesis and inflammation in vitro and in vivo. Food Sci Biotechnol 2019;28:1543-51. [PMID: 31695954 DOI: 10.1007/s10068-019-00579-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Molina PE. Mechanisms Involved in Disruption of Adipose Tissue Mass Resulting from Chronic Unhealthy Alcohol Consumption. Alcohol Clin Exp Res 2016;40:2296-8. [PMID: 27716963 DOI: 10.1111/acer.13219] [Reference Citation Analysis]
37 Sasaki Y, Asahiyama M, Tanaka T, Yamamoto S, Murakami K, Kamiya W, Matsumura Y, Osawa T, Anai M, Fruchart JC, Aburatani H, Sakai J, Kodama T. Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content. Sci Rep 2020;10:7818. [PMID: 32385406 DOI: 10.1038/s41598-020-64902-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
38 Zhou J, Zhang N, Aldhahrani A, Soliman MM, Zhang L, Zhou F. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Front Immunol 2022;13:956688. [DOI: 10.3389/fimmu.2022.956688] [Reference Citation Analysis]
39 Jonscher KR, Bruce KD. Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. Adv Exp Med Biol 2019;1134:33-58. [PMID: 30919331 DOI: 10.1007/978-3-030-12668-1_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Sangouni AA, Ghavamzadeh S. A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach. Diabetes Metab Syndr 2019;13:2917-22. [PMID: 31425956 DOI: 10.1016/j.dsx.2019.07.063] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
41 Shaw TA, Singaravelu R, Powdrill MH, Nhan J, Ahmed N, Özcelik D, Pezacki JP. MicroRNA-124 Regulates Fatty Acid and Triglyceride Homeostasis. iScience 2018;10:149-57. [PMID: 30528902 DOI: 10.1016/j.isci.2018.11.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
42 Malik A, Nadeem M, Malik MI. Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis. Clin J Gastroenterol 2021. [PMID: 34370218 DOI: 10.1007/s12328-021-01491-7] [Reference Citation Analysis]
43 Lim HS, Choi J, Lee B, Kim SG, Kim YS, Yoo JJ. Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. Clin Nutr Res 2020;9:182-94. [PMID: 32789148 DOI: 10.7762/cnr.2020.9.3.182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chen-Liaw AY, Hammel G, Gomez G. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells. In Vitro Cell Dev Biol Anim 2017;53:721-7. [PMID: 28707223 DOI: 10.1007/s11626-017-0181-y] [Reference Citation Analysis]
45 Dibba P, Cholankeril R, Li AA, Patel M, Fayek M, Dibble C, Okpara N, Hines A, Ahmed A. Hepatitis C in Pregnancy. Diseases 2018;6:E31. [PMID: 29702563 DOI: 10.3390/diseases6020031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
46 Ghazali R, Mehta KJ, Bligh SA, Tewfik I, Clemens D, Patel VB. High omega arachidonic acid/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cells. World J Hepatol 2020; 12(3): 84-98 [PMID: 32231762 DOI: 10.4254/wjh.v12.i3.84] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
47 van Ommen B, van den Broek T, de Hoogh I, van Erk M, van Someren E, Rouhani-Rankouhi T, Anthony JC, Hogenelst K, Pasman W, Boorsma A, Wopereis S. Systems biology of personalized nutrition. Nutr Rev 2017;75:579-99. [PMID: 28969366 DOI: 10.1093/nutrit/nux029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
48 Prins GH, Luangmonkong T, Oosterhuis D, Mutsaers HAM, Dekker FJ, Olinga P. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. Nutrients 2019;11:E507. [PMID: 30818824 DOI: 10.3390/nu11030507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
49 Lin TA, Ke BJ, Cheng SC, Lee CL. Red Quinoa Bran Extract Prevented Alcoholic Fatty Liver Disease via Increasing Antioxidative System and Repressing Fatty Acid Synthesis Factors in Mice Fed Alcohol Liquid Diet. Molecules 2021;26:6973. [PMID: 34834064 DOI: 10.3390/molecules26226973] [Reference Citation Analysis]
50 Huang Y, Wang X, Zhang L, Zheng K, Xiong J, Li J, Cong C, Gong Z, Mao J. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. Comput Math Methods Med 2022;2022:7888076. [PMID: 35677177 DOI: 10.1155/2022/7888076] [Reference Citation Analysis]
51 Li YY, Tang D, Du YL, Cao CY, Nie YQ, Cao J, Zhou YJ. Fatty liver mediated by peroxisome proliferator-activated receptor-α DNA methylation can be reversed by a methylation inhibitor and curcumin. J Dig Dis 2018;19:421-30. [PMID: 29802754 DOI: 10.1111/1751-2980.12610] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]